Header Logo

Gary Schaer

Concepts (356)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Infarction
22
2022
147
2.260
Why?
Angioplasty, Balloon, Coronary
18
2022
41
2.200
Why?
ST Elevation Myocardial Infarction
3
2022
10
1.510
Why?
Percutaneous Coronary Intervention
3
2022
26
1.320
Why?
Stem Cell Transplantation
6
2018
43
1.270
Why?
Coronary Restenosis
5
2015
11
1.160
Why?
Stents
11
2004
86
1.030
Why?
Antigens, CD34
6
2018
14
0.960
Why?
Angina Pectoris
6
2018
18
0.860
Why?
Cicatrix
1
2022
8
0.820
Why?
Nanoparticles
1
2022
11
0.820
Why?
Electrocardiography
7
2015
119
0.790
Why?
Coronary Angiography
10
2022
84
0.790
Why?
No-Reflow Phenomenon
1
2022
1
0.790
Why?
Cardiac Catheterization
5
2017
72
0.750
Why?
Brachytherapy
5
2004
56
0.750
Why?
Myocardial Ischemia
3
2017
43
0.710
Why?
Myocardium
10
2018
105
0.680
Why?
MicroRNAs
2
2015
54
0.590
Why?
Triage
2
2015
21
0.580
Why?
Drug-Eluting Stents
2
2015
16
0.570
Why?
Coronary Artery Disease
6
2016
141
0.570
Why?
Heart Injuries
1
2017
3
0.570
Why?
Body Surface Potential Mapping
1
2017
3
0.570
Why?
Stem Cells
4
2022
41
0.560
Why?
Heart Aneurysm
1
2017
8
0.560
Why?
Heart Failure, Systolic
1
2016
6
0.540
Why?
Graft Occlusion, Vascular
4
2004
21
0.540
Why?
Humans
58
2022
28554
0.530
Why?
Heart Ventricles
1
2017
115
0.530
Why?
Cell- and Tissue-Based Therapy
4
2016
13
0.530
Why?
Emergency Service, Hospital
4
2015
259
0.510
Why?
Vascular Remodeling
1
2015
4
0.490
Why?
Vascular System Injuries
1
2015
5
0.490
Why?
Genetic Therapy
3
2013
85
0.470
Why?
Catheters
2
2021
17
0.460
Why?
Early Diagnosis
1
2014
67
0.450
Why?
Animals
15
2022
3814
0.440
Why?
Hematopoietic Stem Cells
1
2012
11
0.420
Why?
Needles
1
2012
21
0.410
Why?
Ventricular Dysfunction, Left
3
2016
46
0.410
Why?
Inpatients
1
2014
150
0.400
Why?
Ventricular Function, Left
6
2016
45
0.400
Why?
Neovascularization, Physiologic
3
2016
24
0.390
Why?
Middle Aged
35
2018
9322
0.380
Why?
Male
42
2018
15401
0.370
Why?
Treatment Outcome
23
2021
3622
0.370
Why?
Myocardial Revascularization
4
2004
20
0.370
Why?
Hematopoietic Stem Cell Transplantation
1
2012
117
0.370
Why?
Strontium Radioisotopes
4
2003
9
0.360
Why?
Heart Failure
5
2016
179
0.360
Why?
Coronary Disease
6
2003
66
0.360
Why?
Platelet Aggregation Inhibitors
2
2016
49
0.360
Why?
Angiogenesis Inducing Agents
1
2010
4
0.350
Why?
Coronary Stenosis
3
2004
16
0.340
Why?
Beta Particles
4
2003
8
0.320
Why?
Aged
29
2018
9344
0.320
Why?
Time Factors
11
2016
1498
0.320
Why?
Female
34
2018
15821
0.310
Why?
Poloxalene
4
1996
4
0.300
Why?
Transplantation, Autologous
6
2018
170
0.280
Why?
Cardiomyopathy, Dilated
3
2016
7
0.280
Why?
Laser Therapy
2
2004
12
0.280
Why?
Follow-Up Studies
14
2015
1863
0.280
Why?
Gastric Fundus
1
2006
2
0.270
Why?
Gastric Fistula
1
2006
5
0.270
Why?
Electrodes
1
2006
12
0.270
Why?
Pericardium
1
2006
20
0.270
Why?
Defibrillators, Implantable
1
2006
12
0.270
Why?
Double-Blind Method
11
2016
433
0.250
Why?
Myocardial Reperfusion
3
1996
5
0.250
Why?
Myocardial Reperfusion Injury
3
1995
8
0.240
Why?
Platelet Membrane Glycoprotein IIb
1
2004
1
0.230
Why?
Integrin beta3
1
2004
4
0.230
Why?
Myocardial Stunning
1
2004
2
0.230
Why?
Heart Transplantation
1
2004
30
0.230
Why?
Blood Platelets
1
2004
39
0.230
Why?
Embolism, Cholesterol
1
2004
1
0.230
Why?
Vascular Diseases
1
2004
44
0.230
Why?
Echocardiography
3
2017
113
0.220
Why?
Vascular Endothelial Growth Factor A
2
2022
72
0.210
Why?
Coronary Circulation
6
1996
26
0.210
Why?
Adrenal Cortex Hormones
1
2004
116
0.210
Why?
Exercise Tolerance
3
2018
32
0.210
Why?
Receptors, Fc
1
2022
9
0.210
Why?
Complement Activation
1
2022
10
0.210
Why?
Epitopes
1
2022
48
0.200
Why?
Blood Substitutes
3
1995
3
0.200
Why?
Fluorocarbons
3
1995
12
0.200
Why?
Visual Perception
1
2002
34
0.200
Why?
Echocardiography, Doppler
2
2001
27
0.200
Why?
Heart
2
1994
68
0.190
Why?
Macrophages
1
2022
108
0.190
Why?
Hemodynamics
5
2001
71
0.190
Why?
Atherectomy, Coronary
1
2021
2
0.190
Why?
Mammary Arteries
1
2021
9
0.190
Why?
Wound Healing
1
2022
160
0.190
Why?
Cytokines
1
2022
232
0.180
Why?
Prospective Studies
13
2016
1811
0.180
Why?
Thrombolytic Therapy
2
2002
51
0.170
Why?
Mice
2
2022
1467
0.170
Why?
Swine
2
2012
82
0.160
Why?
Dogs
8
1996
193
0.150
Why?
Marital Status
1
2018
11
0.150
Why?
Angioplasty, Balloon
5
2004
13
0.150
Why?
Clinical Trials as Topic
3
2016
239
0.150
Why?
Retrospective Studies
5
2016
3615
0.140
Why?
Mortality
1
2018
90
0.140
Why?
Randomized Controlled Trials as Topic
4
2018
329
0.140
Why?
Injections, Intramuscular
2
2018
7
0.140
Why?
Radionuclide Ventriculography
1
2017
1
0.140
Why?
Diagnosis, Differential
2
2017
373
0.140
Why?
Bone Marrow Transplantation
1
2016
26
0.140
Why?
Endothelial Progenitor Cells
1
2016
1
0.140
Why?
Blood Vessel Prosthesis Implantation
4
2004
21
0.130
Why?
Cardiology
2
2016
57
0.130
Why?
Cardiomyopathies
1
2016
32
0.130
Why?
Education, Medical, Continuing
1
2016
36
0.130
Why?
Imaging, Three-Dimensional
1
2017
235
0.130
Why?
Oxygen Inhalation Therapy
1
1995
20
0.120
Why?
Muscle, Smooth, Vascular
1
2015
6
0.120
Why?
Myocytes, Smooth Muscle
1
2015
7
0.120
Why?
Blood Cells
1
2015
4
0.120
Why?
Hospital Design and Construction
1
2015
5
0.120
Why?
Stroke Volume
4
2002
58
0.120
Why?
Severity of Illness Index
3
2004
990
0.120
Why?
Patient Transfer
1
2014
23
0.120
Why?
Shock, Septic
3
1990
69
0.120
Why?
Equipment Design
3
2012
155
0.120
Why?
Atherosclerosis
1
2015
56
0.120
Why?
Gene Transfer Techniques
2
2005
29
0.110
Why?
Mesenchymal Stem Cell Transplantation
2
2016
32
0.110
Why?
Referral and Consultation
1
2014
91
0.110
Why?
Predictive Value of Tests
4
2003
496
0.110
Why?
Biomarkers
2
2016
601
0.110
Why?
Fibrinolytic Agents
4
2010
59
0.110
Why?
Angina, Stable
1
2013
2
0.110
Why?
Survival Rate
3
2004
356
0.110
Why?
Chemokine CXCL12
1
2013
10
0.110
Why?
Plasmids
1
2013
46
0.100
Why?
Radiography, Interventional
1
2012
23
0.100
Why?
Treatment Failure
2
2003
163
0.100
Why?
Microscopy, Fluorescence
1
2012
80
0.100
Why?
Tomography, X-Ray Computed
3
2006
772
0.100
Why?
Cell Survival
1
2012
120
0.100
Why?
Fluoroscopy
1
2012
54
0.100
Why?
Models, Animal
1
2012
120
0.100
Why?
Exercise Test
3
2016
122
0.100
Why?
Radiography
2
2004
651
0.100
Why?
Length of Stay
1
2014
330
0.100
Why?
Early Medical Intervention
1
2012
15
0.100
Why?
Recurrence
2
2003
322
0.100
Why?
Immunohistochemistry
1
2012
364
0.100
Why?
Combined Modality Therapy
5
2004
308
0.100
Why?
Cocaine
1
1990
31
0.090
Why?
Acute Kidney Injury
2
1990
47
0.090
Why?
Registries
2
2010
188
0.090
Why?
Patient Care Team
1
2012
141
0.090
Why?
Product Surveillance, Postmarketing
1
2010
9
0.090
Why?
Adult
12
2016
8173
0.090
Why?
Dinoprostone
1
1990
17
0.090
Why?
Sirolimus
1
2010
20
0.080
Why?
Renal Circulation
2
1990
4
0.080
Why?
Thoracotomy
2
2006
29
0.080
Why?
Disease Models, Animal
3
2004
623
0.080
Why?
Immunosuppressive Agents
1
2010
140
0.080
Why?
Coronary Vessels
3
2016
34
0.080
Why?
Vascular Endothelial Growth Factors
2
2005
14
0.070
Why?
Injections
3
2013
45
0.070
Why?
Collateral Circulation
3
1999
6
0.070
Why?
Stroke
2
2016
276
0.070
Why?
Magnetic Resonance Imaging
1
2012
1197
0.070
Why?
Practice Guidelines as Topic
3
2004
320
0.070
Why?
Pilot Projects
3
2004
438
0.070
Why?
Equipment Failure
1
2006
39
0.070
Why?
Radiography, Thoracic
1
2006
28
0.070
Why?
Foreign-Body Migration
1
2006
19
0.070
Why?
Risk Assessment
3
2004
676
0.070
Why?
Device Removal
1
2006
92
0.070
Why?
Tryptamines
1
2005
1
0.060
Why?
Oxazolidinones
1
2005
2
0.060
Why?
Norepinephrine
1
1985
30
0.060
Why?
Migraine Disorders
1
2005
19
0.060
Why?
United States
4
2016
2191
0.060
Why?
Vascular Resistance
3
1990
13
0.060
Why?
Dopamine
1
1985
87
0.060
Why?
Angiography
2
2003
34
0.060
Why?
Infusions, Intravenous
3
2009
53
0.060
Why?
Peripheral Vascular Diseases
1
2004
6
0.060
Why?
Ischemia
1
2004
23
0.060
Why?
Extremities
1
2004
28
0.060
Why?
Thromboembolism
1
2004
17
0.060
Why?
Ultrasonography, Doppler
1
2004
16
0.060
Why?
Neutrophils
2
1995
110
0.060
Why?
Radiology, Interventional
1
2004
6
0.060
Why?
Calcinosis
1
2004
49
0.060
Why?
Lower Extremity
1
2004
40
0.060
Why?
Iodine Compounds
1
2003
1
0.060
Why?
Fenoldopam
1
2003
1
0.060
Why?
Dopamine Agonists
1
2003
17
0.060
Why?
Hematologic Agents
1
2003
3
0.060
Why?
Single-Blind Method
1
2004
111
0.050
Why?
Angina, Unstable
1
2003
12
0.050
Why?
Lymphokines
1
2003
9
0.050
Why?
Endothelial Growth Factors
1
2003
10
0.050
Why?
Saphenous Vein
1
2003
5
0.050
Why?
Risk Factors
2
2016
2414
0.050
Why?
Vasodilator Agents
1
2003
30
0.050
Why?
Acute Disease
1
2004
208
0.050
Why?
Rhodotorula
1
2003
1
0.050
Why?
Brain Ischemia
1
2004
63
0.050
Why?
Contrast Media
1
2003
75
0.050
Why?
Endpoint Determination
1
2003
22
0.050
Why?
Heart Valve Prosthesis
1
2003
13
0.050
Why?
DNA
1
2003
104
0.050
Why?
Endocarditis, Bacterial
1
2003
12
0.050
Why?
Mycoses
1
2003
23
0.050
Why?
Statistics as Topic
1
2003
112
0.050
Why?
Intercellular Signaling Peptides and Proteins
1
2003
56
0.050
Why?
Necrosis
2
1994
26
0.050
Why?
Incidence
2
2003
774
0.050
Why?
Heart Diseases
1
2003
70
0.050
Why?
Hypothermia, Induced
1
2002
16
0.050
Why?
Death
1
2003
47
0.050
Why?
Kidney Diseases
1
2003
109
0.050
Why?
Illinois
1
2003
248
0.050
Why?
Multivariate Analysis
1
2003
333
0.050
Why?
Transplantation, Homologous
1
2003
286
0.050
Why?
Kidney Failure, Chronic
1
2003
165
0.050
Why?
Aged, 80 and over
5
2016
4901
0.050
Why?
Diastole
1
2001
32
0.050
Why?
Reoperation
2
2003
917
0.050
Why?
Dose-Response Relationship, Drug
2
2013
352
0.050
Why?
Surface-Active Agents
2
1999
5
0.040
Why?
Technetium Tc 99m Sestamibi
2
1999
11
0.040
Why?
Postoperative Complications
2
2004
934
0.040
Why?
Reproducibility of Results
1
2002
732
0.040
Why?
Quality of Life
2
2016
659
0.040
Why?
Cardiology Service, Hospital
1
1997
2
0.040
Why?
Kaplan-Meier Estimate
1
2018
180
0.040
Why?
Cardiovascular Agents
2
2012
27
0.040
Why?
Endothelin-1
1
1996
3
0.030
Why?
Infusions, Intra-Arterial
1
2016
1
0.030
Why?
Early Termination of Clinical Trials
1
2016
1
0.030
Why?
Blood Pressure
2
1990
207
0.030
Why?
Femoral Artery
1
2016
5
0.030
Why?
Placebos
1
1996
71
0.030
Why?
Radial Artery
1
2016
7
0.030
Why?
Salvage Therapy
1
1996
36
0.030
Why?
Practice Patterns, Physicians'
1
1997
122
0.030
Why?
Hemorrhage
1
2016
82
0.030
Why?
Drug Therapy, Combination
1
2016
184
0.030
Why?
Risk
1
2016
207
0.030
Why?
Academic Medical Centers
2
2012
137
0.030
Why?
Chemotaxis, Leukocyte
1
1994
11
0.030
Why?
Clinical Competence
1
1997
248
0.030
Why?
Gases
1
1994
5
0.030
Why?
Hospitals, Community
1
2014
14
0.030
Why?
Recovery of Function
1
2016
300
0.030
Why?
Hospitals, University
1
2014
28
0.030
Why?
Ventricular Fibrillation
1
1994
15
0.030
Why?
Rats, Sprague-Dawley
1
2015
342
0.030
Why?
Time-to-Treatment
1
2014
35
0.030
Why?
Cooperative Behavior
1
2014
78
0.030
Why?
Mice, Knockout
1
2015
317
0.030
Why?
Patient-Centered Care
1
2014
59
0.030
Why?
Cells, Cultured
1
2015
539
0.030
Why?
Mice, Inbred C57BL
1
2015
437
0.030
Why?
Rats
1
2015
684
0.030
Why?
Lactates
2
1990
4
0.030
Why?
Natriuretic Peptide, Brain
1
2013
10
0.030
Why?
Glomerular Filtration Rate
2
1990
53
0.030
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
2
2003
8
0.030
Why?
Angioplasty, Balloon, Laser-Assisted
1
1992
1
0.030
Why?
Peptide Fragments
1
2013
77
0.030
Why?
Positron-Emission Tomography
1
2013
90
0.030
Why?
Delayed Diagnosis
1
2012
11
0.020
Why?
Critical Pathways
1
2012
21
0.020
Why?
Logistic Models
2
2004
398
0.020
Why?
Clinical Protocols
1
2012
60
0.020
Why?
Guideline Adherence
1
2012
65
0.020
Why?
Disease Management
1
2012
115
0.020
Why?
Phentolamine
1
1990
1
0.020
Why?
Propranolol
1
1990
4
0.020
Why?
Vasoconstriction
1
1990
16
0.020
Why?
Survival Analysis
2
2002
267
0.020
Why?
Thermodilution
1
1990
6
0.020
Why?
Renal Veins
1
1990
3
0.020
Why?
Creatinine
2
2003
53
0.020
Why?
Quality Improvement
1
2012
161
0.020
Why?
Off-Label Use
1
2010
6
0.020
Why?
Escherichia coli Infections
1
1990
26
0.020
Why?
Macaca fascicularis
1
1990
25
0.020
Why?
Quality Control
1
2010
33
0.020
Why?
Injections, Intra-Arterial
1
1989
5
0.020
Why?
Diabetes Mellitus, Type 1
1
2010
24
0.020
Why?
Prednisone
1
1989
65
0.020
Why?
Kidney
1
1990
175
0.020
Why?
Streptokinase
1
1987
1
0.020
Why?
Cohort Studies
1
2013
1942
0.020
Why?
Young Adult
1
2013
2104
0.020
Why?
Infusions, Parenteral
1
1985
9
0.020
Why?
Cardiac Output
1
1985
14
0.020
Why?
Drug Combinations
1
1985
36
0.020
Why?
Serotonin Receptor Agonists
1
2005
4
0.020
Why?
Heart Rate
1
1985
117
0.010
Why?
Chi-Square Distribution
1
2004
146
0.010
Why?
Economics, Pharmaceutical
1
2003
3
0.010
Why?
Factor Xa Inhibitors
1
2003
5
0.010
Why?
Dipeptides
1
1983
2
0.010
Why?
Aortic Valve
1
2003
26
0.010
Why?
Oligopeptides
1
1983
24
0.010
Why?
Antifungal Agents
1
2003
44
0.010
Why?
Safety
1
2002
45
0.010
Why?
Radionuclide Angiography
1
2002
1
0.010
Why?
Feasibility Studies
1
2002
233
0.010
Why?
Manometry
1
2001
17
0.010
Why?
Random Allocation
1
2002
130
0.010
Why?
Hypertrophy, Left Ventricular
1
2001
25
0.010
Why?
Tomography, Emission-Computed, Single-Photon
1
2002
81
0.010
Why?
Patient Dropouts
1
2000
28
0.010
Why?
Poloxamer
1
1999
3
0.010
Why?
Computer Systems
1
1999
7
0.010
Why?
Radionuclide Imaging
1
1999
43
0.010
Why?
Prognosis
1
2002
827
0.010
Why?
American Heart Association
1
1998
18
0.010
Why?
Credentialing
1
1997
8
0.010
Why?
Hospitals, Urban
1
1997
32
0.010
Why?
Coronary Artery Bypass
1
1997
30
0.010
Why?
Health Services Research
1
1997
42
0.010
Why?
Societies, Medical
1
1998
153
0.010
Why?
Odds Ratio
1
1997
269
0.010
Why?
Hospital Mortality
1
1997
148
0.010
Why?
Rabbits
1
1995
194
0.010
Why?
Chicago
1
1997
942
0.010
Why?
Catecholamines
1
1990
9
0.010
Why?
Calibration
1
1990
21
0.010
Why?
Catheters, Indwelling
1
1990
24
0.010
Why?
Enterobacteriaceae Infections
1
1990
48
0.010
Why?
Fibroblasts
1
1989
58
0.010
Why?
Lymphocytes
1
1989
63
0.010
Why?
Drug Administration Schedule
1
1989
166
0.010
Why?
Staphylococcal Infections
1
1990
158
0.000
Why?
Anemia, Aplastic
1
1986
1
0.000
Why?
Regional Blood Flow
1
1986
8
0.000
Why?
Oxygen Consumption
1
1986
51
0.000
Why?
Acquired Immunodeficiency Syndrome
1
1986
45
0.000
Why?
Saralasin
1
1983
1
0.000
Why?
Teprotide
1
1983
1
0.000
Why?
Enalapril
1
1983
4
0.000
Why?
Hypotension, Orthostatic
1
1983
11
0.000
Why?
Neoplasms
1
1986
241
0.000
Why?
Long-Term Care
1
1983
58
0.000
Why?
Administration, Oral
1
1983
111
0.000
Why?
Chronic Disease
1
1983
442
0.000
Why?
Adolescent
1
1986
2323
0.000
Why?
Schaer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (356)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_